source
- AbbVie commits £120 million to new Oxford R&D hub, boosting UK life‑science footprintAbbVie announced a £120 million ($160 million) investment to expand its research footprint in the United Kingdom. The company will open a new 12,000‑square‑foot R&D facility in Oxford, joining its…
- Novartis ends $800M neuroscience partnership with BioArctic after 14 monthsNovartis signed an $800 million neuroscience partnership with BioArctic in August 2025, providing $30 million upfront to merge BioArctic’s BrainTransporter technology with a Novartis antibody targe…